oppn parties Vaccine Production Needs To Be Increased And More Vaccines Need To Be Approved

News Snippets

  • The Indian envoy in Bangladesh was summoned by the country's government over the breach in the Bangladesh mission in Agartala
  • Bank account to soon have 4 nominees each
  • TMC and SP stayed away from the INDIA bloc protest over the Adani issue in the Lok Sabha
  • Delhi HC stops the police from arresting Nadeem Khan over a viral video which the police claimed promoted 'enmity'. Court says 'India's harmony not so fragile'
  • Trafiksol asked to refund IPO money by Sebi on account of alleged fraud
  • Re goes down to 84.76 against the USD but ends flat after RBI intervenes
  • Sin goods like tobacco, cigarettes and soft drinks likely to face 35% GST in the post-compensation cess era
  • Bank credit growth slows to 11% (20.6% last year) with retail oans also showing a slowdown
  • Stock markets continue their winning streak on Tuesday: Sensex jumps 597 points to 80845 and Nifty gains 181 points to 24457
  • Asian junior hockey: Defending champions India enter the finals by beating Malaysia 3-1, to play Pakistan for the title
  • Chess World title match: Ding Liren salvages a sraw in the 7th game which he almost lost
  • Experts speculate whether Ding Liren wants the world title match against D Gukesh to go into tie-break after he let off Gukesh easily in the 5th game
  • Tata Memorial Hospital and AIIMS have severely criticized former cricketer and Congress leader Navjot Singh Sidhu for claiming that his wife fought back cancer with home remedies like haldi, garlic and neem. The hospitals warned the public for not going for such unproven remedies and not delaying treatment as it could prove fatal
  • 3 persons died and scores of policemen wer injured when a survey of a mosque in Sambhal near Bareilly in UP turned violent
  • Bangladesh to review power pacts with Indian companies, including those of the Adani group
D Gukesh is the new chess world champion at 18, the first teen to wear the crown. Capitalizes on an error by Ding Liren to snatch the crown by winning the final game g
oppn parties
Vaccine Production Needs To Be Increased And More Vaccines Need To Be Approved

By Sunil Garodia
First publised on 2021-04-08 06:32:24

About the Author

Sunil Garodia Editor-in-Chief of indiacommentary.com. Current Affairs analyst and political commentator.

Is India's vaccination programme in the danger of getting derailed? Three things point to this. In the first, more than 10 states have made representations to the Centre for additional stocks saying that their stocks will not last for the next 3-4 days. Maharashtra’s case is particularly grim with reports of several centres in the state stopping vaccination due to low or no stocks. In the second, AstraZeneca has already served a legal notice on Serum Institute for reneging on supply commitments while Serum has petitioned the Centre to provide Rs. 3000 crore to ramp up production. In the third, despite three months having passed since the vaccination drive started, India is still making do with only two vaccine candidates and others have not been approved for inoculation in the country. Russia is willing to get Sputnik manufactured in India and India would do well to approve it after necessary tests. There are other candidates too which can be seriously looked at. India has manufacturing capacity and it should be used gainfully now.

The government has to take these decisions fast. It has to approve other vaccine candidates and get those vaccines manufactured in India. Import is an option but it will be costly as Serum supplies Covishield at a highly-subsidized rate of just Rs. 150 per dose to the government. At the same time, it must look into ways to ramp up production and supplies of both Covishield and Covaxin. Presently, India is administering between 25 to 35 lakh doses per day. At this rate, India needs 9 crore doses per month. At their present production capacity, both Serum Institute and Bharat Biotech are incapable of servicing the vaccine programme. Production has to be ramped up and new vaccines have to be approved if the vaccination drive is to be sustained at current levels and expanded in the near future.